Supreme Court divided over legality of patent reviews
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Abbvie (ABBV) PT Raised to $93 at Citi; Remains sidelined
November 29, 2017 8:14 AM ESTCiti raised its price target on Abbvie (NYSE: ABBV) to $93.00 (from $60.00) while maintaining a Neutral rating. Citi upgraded EPS and TP to reflect a more optimistic base case for the timing of US Humira biosimilar entry. However, Citi is unable to become... More
Morgan Stanley Upgrades Allergen (AGN) to Overweight
November 29, 2017 4:16 AM EST(Updated - November 29, 2017 6:56 AM EST)
(updated to add analyst comment)
Morgan Stanley upgraded Allergen (NYSE: AGN) from Equalweight to Overweight with a price target of $200.00.
Analyst David Risinger likes the attractive risk/reward following the recent decline in the... More
